Cannara Biotech
TSXV-LOVE
NYSE
NYSE
Healthcare
Drug Manufacturers - Specialty & Generic
Global Rank
#25950
Country Rank
#674
Market Cap
80.07 M
Price
0.88
Change (%)
0.00%
Volume
19,365
Cannara Biotech's latest marketcap:
80.07 M
As of 06/07/2025, Cannara Biotech's market capitalization has reached $80.07 M. According to our data, Cannara Biotech is the 25950th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 80.07 M |
| Revenue (ttm) | 68.65 M |
| Net Income (ttm) | 9.78 M |
| Shares Out | 91.43 M |
| EPS (ttm) | 0.1 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 07/18/2025 |
Market Cap Chart
Data Updated: 06/07/2025
Cannara Biotech's yearly market capitalization.
Cannara Biotech has seen its market value grow from C$59.03 M to C$109.72 M since 2020, representing a total increase of 85.88% and an annual compound growth rate (CAGR) of 15.00%.
| Date | Market Cap | Change (%) |
|---|---|---|
| 06/07/2025 | C$109.72 M | 64.71% |
| 12/31/2024 | C$66.61 M | -10.84% |
| 12/29/2023 | C$74.72 M | -10.37% |
| 12/30/2022 | C$83.36 M | -29.55% |
| 12/31/2021 | C$118.32 M | 100.46% |
| 12/31/2020 | C$59.03 M |
Company Profile
About Cannara Biotech Inc.
Cannara Biotech Inc., along with its subsidiaries, specializes in the indoor cultivation, processing, and distribution of cannabis and cannabis-derived products across Canada.
Business Operations
- Cannabis Production: Focuses on high-quality indoor cultivation and processing of cannabis products.
- Distribution: Sells products through wholesalers and online merchandisers.
- Real Estate: Engages in real estate operations to support its business activities.
Company Background
Founded in 2017, Cannara Biotech Inc. is headquartered in Saint-Laurent, Canada, and continues to expand its presence in the cannabis industry.
Frequently Asked Questions
-
What is Cannara Biotech's (TSXV-LOVE) current market cap?As of 06/07/2025, Cannara Biotech (including the parent company, if applicable) has an estimated market capitalization of $80.07 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Cannara Biotech (TSXV-LOVE) rank globally by market cap?Cannara Biotech global market capitalization ranking is approximately 25950 as of 06/07/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.